UHRF1 is a novel diagnostic marker of lung cancer.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMC 2906730)

Published in Br J Cancer on June 01, 2010

Authors

M Unoki1, Y Daigo, J Koinuma, E Tsuchiya, R Hamamoto, Y Nakamura

Author Affiliations

1: Laboratory for Biomarker, The Institute of Physical and Chemical Research, Center for Genomic Medicine, RIKEN, Tokyo 108-8639, Japan. unokim@ims.u-tokyo.ac.jp

Articles citing this

UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma. Cancer Cell (2014) 1.50

Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer. Mol Cell Proteomics (2012) 1.14

Identification and characterization of small molecule inhibitors of a plant homeodomain finger. Biochemistry (2012) 1.11

Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties. J Exp Clin Cancer Res (2011) 1.07

Structural insight into coordinated recognition of trimethylated histone H3 lysine 9 (H3K9me3) by the plant homeodomain (PHD) and tandem tudor domain (TTD) of UHRF1 (ubiquitin-like, containing PHD and RING finger domains, 1) protein. J Biol Chem (2012) 1.04

DNA methylation, its mediators and genome integrity. Int J Biol Sci (2015) 0.96

The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein. Oncogene (2012) 0.96

E2F8 as a Novel Therapeutic Target for Lung Cancer. J Natl Cancer Inst (2015) 0.91

RFTS-deleted DNMT1 enhances tumorigenicity with focal hypermethylation and global hypomethylation. Cell Cycle (2014) 0.89

Long noncoding RNA UPAT promotes colon tumorigenesis by inhibiting degradation of UHRF1. Proc Natl Acad Sci U S A (2016) 0.87

Elevated expression of UHRF1 predicts unfavorable prognosis for patients with hepatocellular carcinoma. Int J Clin Exp Pathol (2015) 0.86

Upregulated UHRF1 promotes bladder cancer cell invasion by epigenetic silencing of KiSS1. PLoS One (2014) 0.85

Regulation of UHRF1 by microRNA-9 modulates colorectal cancer cell proliferation and apoptosis. Cancer Sci (2015) 0.85

Negative regulation of DNMT3A de novo DNA methylation by frequently overexpressed UHRF family proteins as a mechanism for widespread DNA hypomethylation in cancer. Cell Discov (2016) 0.80

MBD4 interacts with and recruits USP7 to heterochromatic foci. J Cell Biochem (2015) 0.79

UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation. Cancer Biol Ther (2015) 0.78

Hemi-methylated DNA opens a closed conformation of UHRF1 to facilitate its histone recognition. Nat Commun (2016) 0.78

UHRF1 overexpression is involved in cell proliferation and biochemical recurrence in prostate cancer after radical prostatectomy. J Exp Clin Cancer Res (2016) 0.77

Multidimensional Proteomics Reveals a Role of UHRF2 in the Regulation of Epithelial-Mesenchymal Transition (EMT). Mol Cell Proteomics (2016) 0.77

Regulation of Ubiquitin-like with Plant Homeodomain and RING Finger Domain 1 (UHRF1) Protein Stability by Heat Shock Protein 90 Chaperone Machinery. J Biol Chem (2016) 0.76

UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis. J Pathol (2015) 0.76

Zebrafish Discoveries in Cancer Epigenetics. Adv Exp Med Biol (2016) 0.75

The prognostic value of UHRF-1 and p53 in gastric cancer. Saudi J Gastroenterol (2016) 0.75

High-throughput strategy to identify inhibitors of histone-binding domains. Methods Enzymol (2012) 0.75

UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma. Oncotarget (2016) 0.75

UHRF1 gene silencing inhibits cell proliferation and promotes cell apoptosis in human cervical squamous cell carcinoma CaSki cells. J Ovarian Res (2016) 0.75

A novel PHD-finger protein 14/KIF4A complex overexpressed in lung cancer is involved in cell mitosis regulation and tumorigenesis. Oncotarget (2017) 0.75

The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer. Oncotarget (2017) 0.75

Articles cited by this

The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature (2007) 8.17

Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. Nature (2008) 3.62

Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1. Nature (2008) 3.39

The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix. Nature (2008) 3.28

ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation. Mol Cell Biol (2007) 2.69

ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene (2004) 2.30

A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol (2008) 2.01

Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene (2003) 1.91

UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells. Nucleic Acids Res (2008) 1.80

Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth. Mol Biol Cell (2005) 1.68

Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology (2005) 1.61

ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells. Br J Cancer (2003) 1.53

ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression. Cancer Res (2000) 1.51

Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas. Cancer Res (2007) 1.42

Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer. Int J Oncol (2006) 1.38

Trends in lung cancer incidence by histological type in Osaka, Japan. Jpn J Clin Oncol (2008) 1.20

Tobacco smoking and lung cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol (2006) 1.19

Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. Cancer Res (2005) 1.18

UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer. Br J Cancer (2009) 1.18

A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis. Cancer Res (2005) 1.16

Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions? Hum Pathol (2005) 1.11

UHRF1 recruits the histone acetyltransferase Tip60 and controls its expression and activity. Biochem Biophys Res Commun (2009) 1.10

ADAM8 as a novel serological and histochemical marker for lung cancer. Clin Cancer Res (2004) 1.10

UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer. Breast Cancer Res Treat (2009) 1.06

Identification of novel differentially expressed genes in human astrocytomas by cDNA representational difference analysis. Brain Res Mol Brain Res (2005) 0.99

Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer. Anticancer Res (2005) 0.98

From cancer genomics to thoracic oncology: discovery of new biomarkers and therapeutic targets for lung and esophageal carcinoma. Gen Thorac Cardiovasc Surg (2008) 0.89

Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas. Br J Cancer (2009) 0.86

The significance of tumour markers as an indication for mediastinoscopy in non-small cell lung cancer. Respirology (2003) 0.80

Articles by these authors

Sequence analysis of the genome of the unicellular cyanobacterium Synechocystis sp. strain PCC6803. II. Sequence determination of the entire genome and assignment of potential protein-coding regions. DNA Res (1996) 28.37

Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82

Variable number of tandem repeat (VNTR) markers for human gene mapping. Science (1987) 25.71

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (1989) 11.53

Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science (1991) 9.89

Quantum computers. Nature (2010) 6.79

A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature (2000) 6.01

When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain (1995) 5.97

p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell (2000) 5.64

Allelotype of colorectal carcinomas. Science (1989) 5.54

The action of tetrodotoxin on electrogenic components of squid giant axons. J Gen Physiol (1965) 5.42

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet (2000) 5.26

Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science (1993) 5.22

Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet (1992) 5.14

Complete genome structure of the nitrogen-fixing symbiotic bacterium Mesorhizobium loti. DNA Res (2000) 4.94

Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science (1993) 4.63

Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science (1997) 4.62

The gene for familial polyposis coli maps to the long arm of chromosome 5. Science (1987) 4.48

Transient regulation of protein synthesis in Escherichia coli upon shift-up of growth temperature. J Bacteriol (1978) 4.38

Complete genomic sequence of the filamentous nitrogen-fixing cyanobacterium Anabaena sp. strain PCC 7120. DNA Res (2001) 4.27

A primary genetic map of markers of human chromosome 10. Genomics (1988) 4.23

Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res (1992) 4.21

Complete genome sequence of the alkaliphilic bacterium Bacillus halodurans and genomic sequence comparison with Bacillus subtilis. Nucleic Acids Res (2000) 4.11

Identification and characterization of the potential promoter regions of 1031 kinds of human genes. Genome Res (2001) 4.03

Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature (1988) 3.96

An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature (1998) 3.86

Diverse transcriptional initiation revealed by fine, large-scale mapping of mRNA start sites. EMBO Rep (2001) 3.47

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology (2000) 3.42

Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci (2002) 3.28

Rapid confirmation of single copy lambda prophage integration by PCR. Nucleic Acids Res (1994) 3.19

Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res (2001) 3.18

A high-throughput SNP typing system for genome-wide association studies. J Hum Genet (2001) 3.18

Isolation and mapping of a polymorphic DNA sequence (pTHH22) on chromosome 9 [D9S12]. Nucleic Acids Res (1988) 3.17

IL-6 is produced by osteoblasts and induces bone resorption. J Immunol (1990) 3.14

Gene organization deduced from the complete sequence of liverwort Marchantia polymorpha mitochondrial DNA. A primitive form of plant mitochondrial genome. J Mol Biol (1992) 3.11

Molecular detection of microscopic and submicroscopic deletions associated with Miller-Dieker syndrome. Am J Hum Genet (1988) 2.97

Mapping of mutation causing Friedreich's ataxia to human chromosome 9. Nature (1988) 2.96

A tripeptide 'anticodon' deciphers stop codons in messenger RNA. Nature (2000) 2.90

Localisation of atopy and beta subunit of high-affinity IgE receptor (Fc epsilon RI) on chromosome 11q. Lancet (1993) 2.88

Mutations truncating the EP300 acetylase in human cancers. Nat Genet (2000) 2.84

Specific deficit of the ON response in visual transmission by targeted disruption of the mGluR6 gene. Cell (1995) 2.81

A mapped set of genetic markers for human chromosome 9. Genomics (1988) 2.80

Genetic mapping of autosomal dominant Charcot-Marie-Tooth disease in a large French-Acadian kindred: identification of new linked markers on chromosome 17. Am J Hum Genet (1990) 2.77

Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat Genet (1998) 2.77

Experimental investigation of geologically produced antineutrinos with KamLAND. Nature (2005) 2.75

Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res (1992) 2.72

A primary genetic linkage map for human chromosome 12. Genomics (1987) 2.72

Requirement of CD9 on the egg plasma membrane for fertilization. Science (2000) 2.65

Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res (1987) 2.65

Complete structure of the chloroplast genome of Arabidopsis thaliana. DNA Res (1999) 2.63

Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat (1993) 2.63

A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur J Immunol (1994) 2.62

Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. Neuron (1996) 2.62

Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res (1990) 2.57

A radiation hybrid map of the rat genome containing 5,255 markers. Nat Genet (1999) 2.54

Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J Neurosci (2001) 2.54

Association studies of 33 single nucleotide polymorphisms (SNPs) in 29 candidate genes for bronchial asthma: positive association a T924C polymorphism in the thromboxane A2 receptor gene. Hum Genet (2000) 2.50

p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol Cell (2001) 2.47

Helium-3 emission related to volcanic activity. Science (1984) 2.43

Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res (1998) 2.42

Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci U S A (2000) 2.38

Musashi1: an evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev Neurosci (2000) 2.36

A large scale analysis of cDNA in Arabidopsis thaliana: generation of 12,028 non-redundant expressed sequence tags from normalized and size-selected cDNA libraries. DNA Res (2000) 2.33

Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med (1990) 2.32

The human CCG1 gene, essential for progression of the G1 phase, encodes a 210-kilodalton nuclear DNA-binding protein. Mol Cell Biol (1991) 2.30

Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected]. JAMA (1989) 2.29

Biochemical and genetic analysis of the effects of amylose-extender mutation in rice endosperm. Plant Physiol (2001) 2.28

Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts. Oncogene (1999) 2.27

Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene (2001) 2.25

The Saccharomyces cerevisiae genes (CMP1 and CMP2) encoding calmodulin-binding proteins homologous to the catalytic subunit of mammalian protein phosphatase 2B. Mol Gen Genet (1991) 2.23

Developmentally regulated postsynaptic localization of a metabotropic glutamate receptor in rat rod bipolar cells. Cell (1994) 2.20

Virus associated with S.M.O.N. in Japan. Lancet (1971) 2.19

Mutation analysis in the BRCA2 gene in primary breast cancers. Nat Genet (1996) 2.18

Novel proteins of the phosphotransferase system encoded within the rpoN operon of Escherichia coli. Enzyme IIANtr affects growth on organic nitrogen and the conditional lethality of an erats mutant. J Biol Chem (1995) 2.17

Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17

Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16

Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet (1995) 2.15

A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J Med Genet (2008) 2.15

Cloning, characterization and nucleotide sequences of two cDNAs encoding human pancreatic trypsinogens. Gene (1986) 2.14

Autoregulation of RNase III operon by mRNA processing. EMBO J (1989) 2.11

A detailed genetic map of the long arm of chromosome 11. Genomics (1990) 2.11

Coherent dynamics of a flux qubit coupled to a harmonic oscillator. Nature (2004) 2.07

Purification and characterization of metallo-beta-lactamase from Serratia marcescens. Microbiol Immunol (1995) 2.06

Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res (1993) 2.06

Genomic structure of human mismatch repair gene, hMLH1, and its mutation analysis in patients with hereditary non-polyposis colorectal cancer (HNPCC) Hum Mol Genet (1995) 2.05

Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res (1998) 2.02

Identification of the prfC gene, which encodes peptide-chain-release factor 3 of Escherichia coli. Proc Natl Acad Sci U S A (1994) 2.00

Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem (1999) 1.98

Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology (1991) 1.97

Role of the putative membrane-bound endo-1,4-beta-glucanase KORRIGAN in cell elongation and cellulose synthesis in Arabidopsis thaliana. Plant Cell Physiol (2001) 1.97

Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J (2006) 1.92

Monitoring of methyl jasmonate-responsive genes in Arabidopsis by cDNA macroarray: self-activation of jasmonic acid biosynthesis and crosstalk with other phytohormone signaling pathways. DNA Res (2001) 1.92

Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res (2001) 1.91

A rare tRNA-Arg(CCU) that regulates Ty1 element ribosomal frameshifting is essential for Ty1 retrotransposition in Saccharomyces cerevisiae. Genetics (1993) 1.90

Mapping of a gene determining tuberous sclerosis to human chromosome 11q14-11q23. Genomics (1990) 1.90

A large scale structural analysis of cDNAs in a unicellular green alga, Chlamydomonas reinhardtii. I. Generation of 3433 non-redundant expressed sequence tags. DNA Res (1999) 1.90

A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene (1997) 1.88

The nucleotide sequence of the cloned nusA gene and its flanking region of Escherichia coli. Nucleic Acids Res (1984) 1.87

Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics (2001) 1.85